Feasibility of herpes simplex virus type 1 mutants labeled with radionuclides for tumor treatment.

Abstract excerpt

For over one hundred years, viruses have been recognized as capable of killing tumor cells. At present, people are still researching and constructing more suitable oncolytic viruses for treating different malignant tumors. Although extensive studies have demonstrated that herpes simplex virus type 1 (HSV-1) is the most potential oncolytic virus, therapies based on herpes simplex virus type 1 vectors still arouse...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Vectors
• Share to Herpesvirus 1, Human
• Share to Mutation